Evidence map›Paper›PMID 32214621›Full record

ArticleChemicke zvesti2013

Methyl-2-arylidene hydrazinecarbodithioates: synthesis and biological activity.

Manojkumar Mahapatra, Umasankar Kulandaivelu, Philipp Saiko, Geraldine Graser, Thomas Szekeres, Graciela Andrei, Robert Snoeck, Jan Balzarini, Venkatesan Jayaprakash

Abstract read
In one paragraph

Article in Chemicke zvesti, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Manojkumar Mahapatra1346Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi, Jharkhand 835 215 India.
Umasankar Kulandaivelu2346Medicinal Chemistry Research Division, Vaagdevi College of Pharmacy, Hanamkonda, Warangal, Andhra Pradesh 506 001 India.
Philipp SaikoDepartment of Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna - Medical University of Vienna, Waehringer, Guertel 18-20, A-1090 Vienna Austria.
Geraldine GraserDepartment of Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna - Medical University of Vienna, Waehringer, Guertel 18-20, A-1090 Vienna Austria.
Thomas SzekeresDepartment of Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna - Medical University of Vienna, Waehringer, Guertel 18-20, A-1090 Vienna Austria.
Graciela Andrei4346Rega Institute for Medical Research, KU Leuven, B-3000, Leuven, Belgium.
Robert Snoeck4346Rega Institute for Medical Research, KU Leuven, B-3000, Leuven, Belgium.
Jan Balzarini4346Rega Institute for Medical Research, KU Leuven, B-3000, Leuven, Belgium.
Venkatesan Jayaprakash1346Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi, Jharkhand 835 215 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methyl-2-arylidene hydrazine-carbodithioate has not been of particular interest to researchers even though its metal complexes are extensively reported on due to their biological activity. This study examined the cytostatic and antiviral activity of twelve methyl-2-arylidene hydrazinecarbodithioates reported by many researchers as intermediates for the synthesis of thiosemicarbazides and the preparation of their metal complexes. Compounds

Indexed as

anticancerantiviralcytotoxicityHL60 cell linemethyl hydrazinecarbodithioateSchiff’s base

Identifiers

PMID32214621
PMCPMC7088650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.